These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26049780)

  • 1. Quantification of Fibrinolysis Using Velocity Curves Measured with Thromboelastometry in Children with Congenital Heart Disease.
    Faraoni D; Van der Linden P; Ducloy-Bouthors AS; Goobie SM; DiNardo JA; Nielsen VG
    Anesth Analg; 2015 Aug; 121(2):486-91. PubMed ID: 26049780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease.
    Faraoni D; Rozen L; Willems A; Torres CS; Pereira LM; Demulder A; Van der Linden P
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):290-7. PubMed ID: 25806960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study.
    Rozen L; Faraoni D; Sanchez Torres C; Willems A; Noubouossie DC; Barglazan D; Van der Linden P; Demulder A
    Eur J Anaesthesiol; 2015 Dec; 32(12):844-50. PubMed ID: 26258658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association Between Cyanosis and Thromboelastometry (ROTEM) in Children With Congenital Heart Defects: A Retrospective Cohort Study.
    Laskine-Holland ML; Kahr WH; Crawford-Lean L; Humpl T; Honjo O; Foreman C; Jain M; O'Leary JD
    Anesth Analg; 2017 Jan; 124(1):23-29. PubMed ID: 27861436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of dynamic parameters of thrombus formation measured on whole blood using rotational thromboelastometry in children undergoing cardiac surgery: a descriptive study.
    Faraoni D; Fenger-Eriksen C; Gillard S; Willems A; Levy JH; Van der Linden P
    Paediatr Anaesth; 2015 Jun; 25(6):573-9. PubMed ID: 25585839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the time to attain maximal clot amplitude after reaching maximal clot formation velocity parameter as a measure of fibrinolysis using rotational thromboelastometry and its application in the assessment of fibrinolytic resistance in septic patients: a prospective observational study: communication from the ISTH SSC Subcommittee on Fibrinolysis.
    Scarlatescu E; Kim PY; Marchenko SP; Tomescu DR
    J Thromb Haemost; 2024 Apr; 22(4):1223-1235. PubMed ID: 38104723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Functional Fibrinolysis in Cord Blood Using Modified Thromboelastography.
    Sidlik R; Strauss T; Morag I; Shenkman B; Tamarin I; Lubetsky A; Livnat T; Kenet G
    Pediatr Blood Cancer; 2016 May; 63(5):839-43. PubMed ID: 26749087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
    Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of remote ischaemic conditioning on coagulation and fibrinolysis.
    Kristiansen J; Grove EL; Rise N; Neergaard-Petersen S; Würtz M; Kristensen SD; Hvas AM
    Thromb Res; 2016 May; 141():129-35. PubMed ID: 27018926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolysis in patients with chemotherapy-induced thrombocytopenia and the effect of platelet transfusion.
    Heubel-Moenen FCJI; Henskens YMC; Verhezen PWM; Wetzels RJH; Schouten HC; Beckers EAM
    J Thromb Haemost; 2019 Jul; 17(7):1073-1084. PubMed ID: 31033178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early thromboelastometry variables predict maximum clot firmness in children undergoing cardiac and non-cardiac surgery.
    Perez-Ferrer A; Vicente-Sanchez J; Carceles-Baron MD; Van der Linden P; Faraoni D
    Br J Anaesth; 2015 Dec; 115(6):896-902. PubMed ID: 26582850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation.
    Nielsen VG; Cohen BM; Cohen E
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):75-81. PubMed ID: 16607085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of fibrinolytic activity in pregnant patients exposed to tissue plasminogen activator: an in vitro study utilizing rotational thromboelastometry.
    Tran A; Katz D
    Int J Obstet Anesth; 2024 Aug; 59():103994. PubMed ID: 38632015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
    Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can RoTEM® analysis be applied for haemostatic monitoring in paediatric congenital heart surgery?
    Andreasen JB; Hvas AM; Christiansen K; Ravn HB
    Cardiol Young; 2011 Dec; 21(6):684-91. PubMed ID: 21729518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysis onset time as diagnostic rotational thromboelastometry parameter for fast detection of hyperfibrinolysis.
    Dekker SE; Viersen VA; Duvekot A; de Jong M; van den Brom CE; van de Ven PM; Schober P; Boer C
    Anesthesiology; 2014 Jul; 121(1):89-97. PubMed ID: 24646494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased resistance to tissue plasminogen activator-induced fibrinolysis in healthy subjects from Thailand.
    White NJ; Taflin N; Lim EB; Akaraborworn O
    Blood Coagul Fibrinolysis; 2018 Jun; 29(4):356-360. PubMed ID: 29337700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Value of Intraoperative Thromboelastometry for the Risk of Perioperative Excessive Blood Loss in Infants and Children Undergoing Congenital Cardiac Surgery: A Retrospective Analysis.
    Kim E; Shim HS; Kim WH; Lee SY; Park SK; Yang JH; Jun TG; Kim CS
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1172-8. PubMed ID: 27474337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FIBTEM PLUS provides an improved thromboelastometry test for measurement of fibrin-based clot quality in cardiac surgery patients.
    Solomon C; Baryshnikova E; Schlimp CJ; Schöchl H; Asmis LM; Ranucci M
    Anesth Analg; 2013 Nov; 117(5):1054-62. PubMed ID: 24108255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early thromboelastometric variables reliably predict maximum clot firmness in patients undergoing cardiac surgery: a step towards earlier decision making.
    Dirkmann D; Görlinger K; Dusse F; Kottenberg E; Peters J
    Acta Anaesthesiol Scand; 2013 May; 57(5):594-603. PubMed ID: 23240733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.